(Report ID: 45060) Drug interactions analysis of:
Doxorubicin Hcl, Cyclophosphamide, Vincristine, Prednisolone, Carbamazepine, Pravastatin, SpironolactoneMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,651 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 6 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 45060 | Feb, 14, 2006 | 52 | Male |
List of drugs the patient takes:
| Drug |
Doxorubicin Hcl |
Cyclophosphamide |
Vincristine |
Prednisolone |
Carbamazepine |
Pravastatin |
Spironolactone |
| Name |
Cryptogenic Organizing Pneumonia |
Neutropenia |
Respiratory Failure |
Results from eHealthMe: 6 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Cryptogenic Organizing Pneumonia | 5 (83.33%) |
Neutropenia | 5 (83.33%) |
Respiratory Failure | 4 (66.67%) |
3) Top co-used drugs drugs reported for the past 12 months:
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Neutropenia | 5 (83.33%) |
2 | Cryptogenic Organizing Pneumonia | 5 (83.33%) |
3 | Respiratory Failure | 4 (66.67%) |
4 | Hypoxia | 1 (16.67%) |
5 | Restrictive Pulmonary Disease | 1 (16.67%) |
6 | Chest X-ray Abnormal | 1 (16.67%) |
7 | Pleuritic Pain | 1 (16.67%) |
8 | Pyrexia | 1 (16.67%) |
| Name | Count |
1 | Omeprazole | 5 |
2 | Furosemide | 2 |
3 | Warfarin Sodium | 2 |
4 | Neulasta | 2 |
5 | Levothyroxine Sodium | 1 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
